BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38282955)

  • 41. Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel disease.
    Korzenik J; Larsen MD; Nielsen J; Kjeldsen J; Nørgård BM
    Aliment Pharmacol Ther; 2019 Aug; 50(3):289-294. PubMed ID: 31267570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stricturing and Fistulizing Crohn's Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease.
    Weizman AV; Sharma R; Afzal NM; Xu W; Walsh S; Stempak JM; Nguyen GC; Croitoru K; Steinhart AH; Silverberg MS
    Dig Dis Sci; 2018 Sep; 63(9):2430-2438. PubMed ID: 29736839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between inflammatory bowel diseases and Parkinson's disease: systematic review and meta-analysis.
    Zhu Y; Yuan M; Liu Y; Yang F; Chen WZ; Xu ZZ; Xiang ZB; Xu RS
    Neural Regen Res; 2022 Feb; 17(2):344-353. PubMed ID: 34269209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
    Card TR; Langan SM; Chu TP
    Dig Dis Sci; 2016 Sep; 61(9):2619-26. PubMed ID: 27193564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammatory bowel disease and psoriasis: modernizing the multidisciplinary approach.
    Hedin CRH; Sonkoly E; Eberhardson M; Ståhle M
    J Intern Med; 2021 Aug; 290(2):257-278. PubMed ID: 33942408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort study.
    Charlton R; Green A; Shaddick G; Snowball J; Nightingale A; Tillett W; Smith CH; McHugh N;
    Ann Rheum Dis; 2018 Feb; 77(2):277-280. PubMed ID: 29092855
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of Psoriasis With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Fu Y; Lee CH; Chi CC
    JAMA Dermatol; 2018 Dec; 154(12):1417-1423. PubMed ID: 30422277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Crohn's-like disease in a patient exposed to anti-Interleukin-17 blockade (Ixekizumab) for the treatment of chronic plaque psoriasis: a case report.
    Smith MK; Pai J; Panaccione R; Beck P; Ferraz JG; Jijon H
    BMC Gastroenterol; 2019 Sep; 19(1):162. PubMed ID: 31488067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
    Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
    J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
    Makredes M; Robinson D; Bala M; Kimball AB
    J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of extra-articular manifestations in axial spondyloarthritis and their influence on TNF-inhibitor prescribing patterns: results from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis.
    Derakhshan MH; Dean L; Jones GT; Siebert S; Gaffney K
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32641447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease.
    Jun YK; Yoon H; Koh SJ; Kim AH; Kim KW; Park JW; Lee HJ; Kang HW; Im JP; Park YS; Kim JS;
    Intest Res; 2023 Apr; 21(2):244-251. PubMed ID: 35929093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Do ethnicity, degree of family relationship, and the spondyloarthritis subtype in affected relatives influence the association between a positive family history for spondyloarthritis and HLA-B27 carriership? Results from the worldwide ASAS cohort.
    van Lunteren M; Sepriano A; Landewé R; Sieper J; Rudwaleit M; van der Heijde D; van Gaalen F
    Arthritis Res Ther; 2018 Aug; 20(1):166. PubMed ID: 30075809
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study.
    Choi YJ; Choi EK; Han KD; Park J; Moon I; Lee E; Choe WS; Lee SR; Cha MJ; Lim WH; Oh S
    World J Gastroenterol; 2019 Jun; 25(22):2788-2798. PubMed ID: 31236001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Finger clubbing in inflammatory bowel disease: association with upper small bowel lesions and need of surgery in Crohn's disease.
    Romeo S; Neri B; Mossa M; Calabrese E; Lolli E; Sena G; Gesuale C; Chiaramonte C; Biancone L
    Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):844-851. PubMed ID: 33136723
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.
    Busingye D; Pollack A; Chidwick K
    PLoS One; 2021; 16(5):e0252458. PubMed ID: 34043730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women.
    Li WQ; Han JL; Chan AT; Qureshi AA
    Ann Rheum Dis; 2013 Jul; 72(7):1200-5. PubMed ID: 22941766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-TNFα antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease: an Irish Cohort Study.
    Kirthi Jeyarajah S; Tobin AM; Hussey M; Scaldaferri F; McNamara D
    QJM; 2017 Jun; 110(6):379-382. PubMed ID: 28069913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk Factors for the Occurrence and Severity of Vertebral Fractures in Inflammatory Bowel Disease Patients: A Nationwide Population-Based Cohort Study.
    Choi A; Jung SH; Kim S; Lee JS
    J Korean Med Sci; 2023 Jul; 38(28):e210. PubMed ID: 37463684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psoriasiform Skin Lesions Are Caused by Anti-TNF Agents Used for the Treatment of Inflammatory Bowel Disease.
    George LA; Gadani A; Cross RK; Jambaulikar G; Ghazi LJ
    Dig Dis Sci; 2015 Nov; 60(11):3424-30. PubMed ID: 26115749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.